Clinical Trial: A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559396) titled 'A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease' on April 24.

Brief Summary: This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with severe renal impairment or end stage renal disease.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Renal Impairment

Intervention: DRUG: INCB123667

Group 1: Single dose administered orally. Group 2: Two single doses administered orally.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ...